BLOATBIOTIC

Serial Number 97621594
732

Registration Progress

Application Filed
Oct 6, 2022
Under Examination
Jun 6, 2023
Approved for Publication
Apr 11, 2023
Published for Opposition
Apr 11, 2023
Registered

Basic Information

Serial Number
97621594
Filing Date
October 6, 2022
Published for Opposition
April 11, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
Dec 6, 2024
Application
Pending
Classes
005

Rights Holder

BIOHM HEALTH INC.

03
Address
425 LITERARY RD.
SUITE 100
CLEVELAND, OH 44113

Ownership History

Biohm Health LLC

Original Applicant
16
Cleveland, OH

Biohm Health LLC

Owner at Publication
16
Cleveland, OH

BIOHM HEALTH INC.

New Owner After Publication #1
03
CLEVELAND, OH

Legal Representation

Attorney
Brian E Turung
USPTO Deadlines 0 active
All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

20 events
Date Code Type Description
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 7, 2024 EX3G S SOU EXTENSION 3 GRANTED
Dec 6, 2024 EXT3 S SOU EXTENSION 3 FILED
Dec 6, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 5, 2024 EX2G S SOU EXTENSION 2 GRANTED
Jun 5, 2024 EXT2 S SOU EXTENSION 2 FILED
Jun 5, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 8, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 6, 2023 EX1G S SOU EXTENSION 1 GRANTED
Dec 6, 2023 EXT1 S SOU EXTENSION 1 FILED
Dec 6, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 6, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 19, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 11, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 11, 2023 PUBO A PUBLISHED FOR OPPOSITION
Mar 22, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 8, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 8, 2023 DOCK D ASSIGNED TO EXAMINER
Oct 31, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Detailed Classifications

Class 005
Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; nutritional supplements, namely, probiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; dietary supplements for medical use, namely, metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal extracts sold as a component ingredient of nutritional supplements and vitamins and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's disease, ulcerative colitis and irritable bowel syndrome

Classification

International Classes
005